149 related articles for article (PubMed ID: 33385012)
1. ANTXR1 Is a Prognostic Biomarker and Correlates With Stromal and Immune Cell Infiltration in Gastric Cancer.
Huang X; Zhang J; Zheng Y
Front Mol Biosci; 2020; 7():598221. PubMed ID: 33385012
[TBL] [Abstract][Full Text] [Related]
2. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway.
Cai C; Dang W; Liu S; Huang L; Li Y; Li G; Yan S; Jiang C; Song X; Hu Y; Gu J
Cancer Sci; 2020 Apr; 111(4):1132-1145. PubMed ID: 31977138
[TBL] [Abstract][Full Text] [Related]
3. Gastric Cancer Tumor Microenvironment Characterization Reveals Stromal-Related Gene Signatures Associated With Macrophage Infiltration.
Wei S; Lu J; Lou J; Shi C; Mo S; Shao Y; Ni J; Zhang W; Cheng X
Front Genet; 2020; 11():663. PubMed ID: 32695142
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of the Immune Cell Infiltration Landscape in Gastric Cancer to Assistant Immunotherapy.
Li C; Pan J; Jiang Y; Yu Y; Jin Z; Chen X
Front Genet; 2021; 12():793628. PubMed ID: 35069691
[No Abstract] [Full Text] [Related]
5. TGFB2 serves as a link between epithelial-mesenchymal transition and tumor mutation burden in gastric cancer.
Yang B; Bai J; Shi R; Shao X; Yang Y; Jin Y; Che X; Zhang Y; Qu X; Liu Y; Li Z
Int Immunopharmacol; 2020 Jul; 84():106532. PubMed ID: 32388013
[TBL] [Abstract][Full Text] [Related]
6. Latest therapeutic target for gastric cancer: Anthrax toxin receptor 1.
Sun KR; Lv HF; Chen BB; Nie CY; Zhao J; Chen XB
World J Gastrointest Oncol; 2021 Apr; 13(4):216-222. PubMed ID: 33889273
[TBL] [Abstract][Full Text] [Related]
7. The Anthrax Toxin Receptor 1 (ANTXR1) Is Enriched in Pancreatic Cancer Stem Cells Derived from Primary Tumor Cultures.
Alcalá S; Martinelli P; Hermann PC; Heeschen C; Sainz B
Stem Cells Int; 2019; 2019():1378639. PubMed ID: 31191663
[TBL] [Abstract][Full Text] [Related]
8. Mining The Cancer Genome Atlas database for tumor mutation burden and its clinical implications in gastric cancer.
Zhao DY; Sun XZ; Yao SK
World J Gastrointest Oncol; 2021 Jan; 13(1):37-57. PubMed ID: 33510848
[TBL] [Abstract][Full Text] [Related]
9.
Su J; Ma Q; Long W; Tang H; Wu C; Luo M; Wang X; Xiao K; Li Y; Xiao Q; Zhang C; Li H; Liu Q
Front Oncol; 2019; 9():1083. PubMed ID: 31681612
[TBL] [Abstract][Full Text] [Related]
10. NOTCH3 is a Prognostic Factor and Is Correlated With Immune Tolerance in Gastric Cancer.
Cui Y; Li Q; Li W; Wang Y; Lv F; Shi X; Tang Z; Shen Z; Hou Y; Zhang H; Mao B; Liu T
Front Oncol; 2020; 10():574937. PubMed ID: 33479597
[TBL] [Abstract][Full Text] [Related]
11. ANTXR1 (TEM8) overexpression in gastric adenocarcinoma makes the protein a potential target of immunotherapy.
Sotoudeh M; Shakeri R; Dawsey SM; Sharififard B; Ahmadbeigi N; Naderi M
Cancer Immunol Immunother; 2019 Oct; 68(10):1597-1603. PubMed ID: 31520110
[TBL] [Abstract][Full Text] [Related]
12. Cross-Talk of Focal Adhesion-Related Gene Defines Prognosis and the Immune Microenvironment in Gastric Cancer.
Mao D; Xu R; Chen H; Chen X; Li D; Song S; He Y; Wei Z; Zhang C
Front Cell Dev Biol; 2021; 9():716461. PubMed ID: 34660578
[No Abstract] [Full Text] [Related]
13. Gastric cancer with enhanced myogenesis is associated with less cell proliferation, enriched epithelial-to-mesenchymal transition and angiogenesis, and poor clinical outcomes.
Chida K; Oshi M; An N; Kanazawa H; Roy AM; Mann GK; Yan L; Endo I; Hakamada K; Takabe K
Am J Cancer Res; 2024; 14(1):355-367. PubMed ID: 38323295
[TBL] [Abstract][Full Text] [Related]
14. Establishment of an Immune Cell Infiltration Score to Help Predict the Prognosis and Chemotherapy Responsiveness of Gastric Cancer Patients.
Jiang Q; Sun J; Chen H; Ding C; Tang Z; Ruan Y; Liu F; Sun Y
Front Oncol; 2021; 11():650673. PubMed ID: 34307129
[TBL] [Abstract][Full Text] [Related]
15. Identification of molecular patterns and prognostic models of epithelial-mesenchymal transition- and immune-combined index in the gastric cancer.
Zhang X; Li Y; Hu P; Xu L; Qiu H
Front Pharmacol; 2022; 13():958070. PubMed ID: 36016566
[No Abstract] [Full Text] [Related]
16. Diagnostic biomarker KIF23 is associated with immune infiltration and immunotherapy response in gastric cancer.
Bai M; Liu X
Front Oncol; 2023; 13():1191009. PubMed ID: 37483517
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of
Zhang X; Huang T; Li Y; Qiu H
Int J Gen Med; 2021; 14():4945-4957. PubMed ID: 34475782
[TBL] [Abstract][Full Text] [Related]
18. CPXM1 correlates to poor prognosis and immune cell infiltration in gastric cancer.
Gu Q; Mi L; Lai C; Guan X; Lu N; Zhan T; Wang G; Lu C; Xu L; Gao X; Zhang J
Heliyon; 2024 Feb; 10(3):e21909. PubMed ID: 38314284
[TBL] [Abstract][Full Text] [Related]
19. The role of anthrax toxin protein receptor 1 as a new mechanosensor molecule and its mechanotransduction in BMSCs under hydrostatic pressure.
Cheng B; Liu Y; Zhao Y; Li Q; Liu Y; Wang J; Chen Y; Zhang M
Sci Rep; 2019 Sep; 9(1):12642. PubMed ID: 31477767
[TBL] [Abstract][Full Text] [Related]
20. Immune Landscape of Invasive Ductal Carcinoma Tumor Microenvironment Identifies a Prognostic and Immunotherapeutically Relevant Gene Signature.
Bao X; Shi R; Zhang K; Xin S; Li X; Zhao Y; Wang Y
Front Oncol; 2019; 9():903. PubMed ID: 31620363
[No Abstract] [Full Text] [Related]
[Next] [New Search]
